Apellis Pharmaceuticals, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 960.57M881.76M760.22M788.73M885.05M
Current Assets
Cash & Equivalents 565.78M640.19M551.80M351.19M411.29M
Short-term Investments 311.87M60.36M1.27M1.11M1.32M
Cash & Current Investments 877.65M700.55M553.07M352.30M412.61M
Receivables - Net 10.10M7.73M206.44M264.93M
Receivables - Other 1.44M3.05M4.53M
Receivables 10.10M9.17M209.50M269.45M
Raw Materials 5.75M29.85M32.72M
Work In Process 10.06M54.10M82.92M
Finished Goods 0.48M1.77M30.71M
Inventory 16.29M85.71M146.36M81.40M
Prepaid Assets 26.88M70.68M36.66M38.82M18.37M
Current Assets 917.19M824.05M719.52M766.33M788.95M
Non-Current Assets
Property, Plant & Equipment (Net) 6.80M6.18M6.15M4.34M2.95M
Other Non-Current Assets 1.27M1.56M1.27M1.31M1.35M
Non-Current Assets 43.38M57.72M40.69M22.40M96.10M
Liabilities
Current Liabilities
Accounts Payables 8.48M16.91M37.34M37.52M38.57M
Payables 8.48M16.91M37.34M37.52M38.57M
Accumulated Expenses 25.00M103.24M95.14M127.81M140.18M
Other Accumulated Expenses 16.11M12.81M13.82M12.17M2.97M
Current Leases 3.69M4.12M5.62M6.44M6.75M
Total Current Liabilities 128.33M131.85M167.61M247.59M185.51M
Non-Current Liabilities
Non-Current Debt 359.49M
Convertible Debt 358.83M189.02M92.74M93.03M93.34M
Operating Leases 15.22M17.08M14.35M11.45M10.20M
Other Non-Current Liabilities 253.64M345.15M2.31M7.97M
Total Non-Current Liabilities 502.37M337.95M591.90M648.54M
Liabilities
Total Liabilities 756.01M683.10M590.35M594.21M656.51M
Shareholder's Equity
Total Debt 359.49M
Common Equity 204.56M198.66M169.87M194.52M228.54M
Shareholder's Equity 204.56M198.66M169.87M194.52M228.54M
Liabilities and Shareholders Equity 960.57M881.76M760.22M788.73M885.05M
Retained Earnings -926.35M-1656.69M-2308.86M-2837.49M-3035.37M
Treasury Shares 0.50M1.23M3.57M4.30M3.96M